[The effect of the use of the drug recognan (citicoline) on the state of higher mental functions in patients with mild cognitive impairment].
S A NemkovaD V SemenovE A PetrovaNikolay N ZavadenkoM Yu VozvyshaevaPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2021)
After 2 weeks of treatment with recognan, there was an improvement in concentration in 81.9%, memory in 50% (p=0.008), verbal imagination productivity in 68.2% (p=0.015), counting functions in 60% (p=0.015), visual-motor coordination and dynamic praxis - in 86.4% (p=0.003), increased speed and efficiency of mental work (p=0.001). After a 30-day course of treatment with recognan, there was an improvement in memory in 58.3% of patients (p=0.007), an increase in concentration in 64%, an improvement in counting functions in 64.3% (p=0.011), verbal imagination productivity in 63.3%, visual-motor coordination and dynamic praxis in 86.4% (p=0.007), speed and efficiency of mental work (p=0.006), which indicates a complex positive effect of recognan on higher mental functions in patients with mild cognitive impairment cognitive impairment.
Keyphrases
- mild cognitive impairment
- cognitive decline
- working memory
- mental health
- cognitive impairment
- end stage renal disease
- climate change
- newly diagnosed
- chronic kidney disease
- emergency department
- ejection fraction
- prognostic factors
- peritoneal dialysis
- patient reported outcomes
- preterm birth
- gestational age
- replacement therapy
- electronic health record